Loading…
Aethlon Medical, Inc. is projected to rise to $2.10 by 2027, a +8% move from its current price of $1.94. AEMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 6/10/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jun 11 | $1.81 | $1.94 | $2.09 | +0.06% |
| Jun 12 | $1.75 | $1.94 | $2.15 | +0.12% |
| Jun 13 | $1.71 | $1.94 | $2.20 | +0.18% |
| Jun 14 | $1.68 | $1.94 | $2.25 | +0.24% |
| Jun 15 | $1.65 | $1.95 | $2.29 | +0.30% |
| Jun 16 | $1.63 | $1.95 | $2.33 | +0.36% |
| Jun 17 | $1.61 | $1.95 | $2.36 | +0.42% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.61 | $1.95 | $2.36 | +0.42% |
| Week 2 | $1.49 | $1.96 | $2.57 | +0.85% |
| Week 3 | $1.41 | $1.96 | $2.74 | +1.28% |
| Week 4 | $1.34 | $1.97 | $2.90 | +1.71% |
| Week 5 | $1.29 | $1.98 | $3.04 | +2.14% |
| Week 6 | $1.24 | $1.99 | $3.19 | +2.57% |
| Week 7 | $1.20 | $2.00 | $3.32 | +3.01% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aethlon Medical, Inc. is a medical therapeutic company that develops novel immunotherapeutic devices to treat cancer and viral infections in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device intended for applications in cancer, life-threatening viral infections, and use in organ transplantation.
The company was founded in 1984 and is based in San Diego, California.
Aethlon Medical, Inc. (AEMD) operates in the Healthcare sector. Its current price is $1.91 and it carries a market cap of $4.48M with a rank of 4987.
The forecasted path for the stock shows a mix of neutral and bullish sentiment across the years. In 2026 the avg price is $1.91, followed by $2.11 in 2027 and $1.95 in 2028, with 2029 at $1.84 and 2030 at $1.72. The trajectory shifts to higher averages in 2032 ($2.62) and 2033 ($2.73), then continues with 2034 ($2.25) and 2035 ($2.30).
By 2040 the avg rises to $3.12 and by 2050 to $6.20, illustrating a long-term upside amid periods of uncertainty.
A major floor 39.3% below — a decisive break under it would weaken the trend.
Price is testing support right now (1.5% away) — a key level to hold.
The nearest ceiling, 58.2% above — a clean break opens room to run.
A major ceiling 80.2% above — clearing it would confirm fresh momentum.
Key AEMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of AEMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.08 | Sell | $2.10 | Sell |
| MA 10 | $2.35 | Sell | $2.19 | Sell |
| MA 20 | $2.23 | Sell | $2.23 | Sell |
| MA 50 | $2.24 | Sell | $2.26 | Sell |
| MA 100 | $2.23 | Sell | $2.84 | Sell |
| MA 200 | $4.17 | Sell | $7.10 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 44.59 | Neutral |
| Stoch RSI (14) | 16.09 | Buy |
| CCI (20) | -70.32 | Neutral |
| Williams %R (14) | -89.66 | Info |
| MACD (12,26,9) | -0.05 | Sell |
| ROC (12) | -1.93 | Sell |
| Bollinger %B (20,2) | 0.32 | Neutral |
| Stochastic %K (14) | 10.34 | Buy |
| TRIX (15) | 0.11 | Buy |
| Awesome (5,34) | -0.17 | Sell |
| Ultimate (7,14,28) | 33.55 | Neutral |
| Momentum (10) | -0.17 | Sell |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 1.89 | Buy |
| ADX (14) | 15.82 | Neutral |
| ATR (14) | 0.15 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 40.
The stock’s SMA50 is $2.24 and the SMA200 is $4.22, placing near-term moves within a bearish context relative to the longer-term trend.
Support sits at $1.91 and resistance at $3.07, with a 30-day price range of $1.18 to $3.10.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.65 | $1.94 | $2.85 | 0% | Neutral | |
| $1.52 | $2.10 | $3.16 | +8% | Neutral | |
| $1.31 | $1.93 | $3.09 | 0% | Neutral | |
| $1.19 | $1.85 | $3.09 | -5% | Neutral | |
| $1.09 | $1.77 | $3.08 | -9% | Neutral | |
| $1.11 | $1.88 | $3.38 | -3% | Neutral | |
| $1.54 | $2.73 | $5.06 | +41% | Bullish | |
| $1.53 | $2.82 | $5.38 | +45% | Bullish | |
| $1.20 | $2.30 | $4.50 | +19% | Neutral | |
| $1.19 | $2.37 | $4.75 | +22% | Bullish | |
| $1.46 | $3.24 | $7.13 | +67% | Bullish | |
| $3.00 | $6.66 | $15.31 | +243% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| June 2026 | $1.65 | $1.94 | $2.31 | +0.00% |
| July 2026 | $1.56 | $1.89 | $2.39 | -2.55% |
| August 2026 | $1.67 | $2.05 | $2.64 | +8.44% |
| September 2026 | $1.67 | $2.08 | $2.73 | +1.50% |
| October 2026 | $1.58 | $1.98 | $2.64 | -4.76% |
| November 2026 | $1.59 | $2.01 | $2.71 | +1.61% |
| December 2026 | $1.63 | $2.09 | $2.85 | +3.70% |
Click any year to see its month-by-month AEMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Aethlon Medical, Inc.'s 2026 outlook centres on $1.94, within a $1.65 to $2.85 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, AEMD could reach as high as $3.16, with a base case around $2.10 and support toward $1.52 — roughly +8% from $1.94. A consolidation phase looks the most probable path here.
Expect AEMD to range from $1.31 to $3.09 through 2028. The $1.93 average target implies a 0% move from current prices. That is -8% versus the projected 2027 average. Price action looks broadly range-bound.
The AEMD price prediction for 2029 points to an average of $1.85 (low $1.19, high $3.09) — a potential decline of -5% on today's $1.94. A consolidation phase looks the most probable path here.
In 2030, AEMD is projected to trade between $1.09 and $3.08, averaging $1.77 — a potential decline of -9% from today's $1.94. That is -4% versus the projected 2029 average. Price action looks broadly range-bound.
Aethlon Medical, Inc.'s 2031 outlook centres on $1.88, within a $1.11 to $3.38 range. That is up +6% on the projected 2030 average. That marks a -3% change versus current levels. A consolidation phase looks the most probable path here.
By 2032, AEMD could reach as high as $5.06, with a base case around $2.73 and support toward $1.54 — roughly +41% from $1.94. Momentum favours further upside here.
Expect AEMD to range from $1.53 to $5.38 through 2033. The $2.82 average target implies a +45% move from current prices. That is up +3% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The AEMD price prediction for 2034 points to an average of $2.30 (low $1.20, high $4.50) — a potential gain of +19% on today's $1.94. Price action looks broadly range-bound.
In 2035, AEMD is projected to trade between $1.19 and $4.75, averaging $2.37 — a potential gain of +22% from today's $1.94. That is up +3% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Aethlon Medical, Inc.'s 2040 outlook centres on $3.24, within a $1.46 to $7.13 range. That is up +37% on the projected 2035 average. That marks a +67% change versus current levels. Momentum favours further upside here.
By 2050, AEMD could reach as high as $15.31, with a base case around $6.66 and support toward $3.00 — roughly +243% from $1.94. Buyers look set to stay in control over this stretch.
Investing $1,000 in AEMD today (≈ 515.463918 AEMD) could be worth
$3,431.03
+$2,431.03 (+243%) by 2050 · US Dollar
Based on the average projected AEMD price of $6.66 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in AEMDwould be worth at today's price.
$1,000 invested in AEMD on Jun 9, 2025 (≈ 43.478261 AEMD) would be worth
$84.35
-$915.65 (-91.6%) today · 0.08× · US Dollar
Based on a AEMD entry price of $23 vs. today's $1.94.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.41 | $804.98 | -19.5% |
| 1 month ago | $2.25 | $862.22 | -13.8% |
| 3 months ago | $1.69 | $1,147.93 | +14.8% |
| 6 months ago | $3.72 | $521.51 | -47.8% |
| 1 year ago | $23 | $84.35 | -91.6% |
| All time (5.0y) ago | $5,192 | $0.37 | -100.0% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our AEMD forecast.
Our base-case forecast reaches $3.90 around 2050.
Implied market cap at $3.90: $9.15M
The multi-year forecast shows a shift from NEUTRAL sentiment through 2031 to BULLISH sentiment in 2032, 2033, 2035, 2040, and 2050.
Key year-by-year outturns include 2030 avg $1.72 with ROI -10.1, 2040 avg $3.12 with ROI 63.6, and 2050 avg $6.20 with ROI 224.6, highlighting substantial longer-term upside potential alongside near-term headwinds.
Max-price forecasts reinforce the upside: 2027 max $3.16, 2032 max $4.87, 2033 max $5.22, 2040 max $6.87, and 2050 max $14.26. These figures underscore a path to higher highs in later years, albeit with notable downside risk in earlier periods. The forecast also notes high volatility, with annualized volatility at 100.
These estimates are not guarantees; they reflect modeled forecasts and carry inherent uncertainty.
Tap a question to reveal the answer.
Avg price is $1.72 with ROI -10.1. The range is $1.06 to $2.99, and sentiment is Neutral.
The forecast shows mixed results: some years are Neutral (2026–2031) while later years turn Bullish (e.g., 2032–2033 and 2040–2050). Notably, 2030 has ROI -10.1, while 2040 shows ROI 63.6 and 2050 ROI 224.6, indicating potential upside but significant risk.
Yes, according to the forecast, the max prices include 2027 $3.16, 2032 $4.87, 2033 $5.22, 2040 $6.87, and 2050 $14.26.
Current price is $1.91 and market cap is $4.48M.
The 30-day range is $1.18 to $3.10.
Aethlon Medical, Inc. Community Discussion
0Share your Aethlon Medical, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.